cnbc.com
FDA commissioner to drug middlemen: You're part of the problem
Drug manufacturers are using several schemes to "hamstring biosimilar competition," and FDA Commissioner Scott Gottlieb worries pharmacy benefit managers have been "complacent participants" in them.
